Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol®, medium chain glycerides and PEG esters

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 5, 2007, Pages 633-640

  Fernandez, Sylvie ^a,b   Jannin, Vincent ^b   Rodier, Jean David ^b   Ritter, Nicolas ^b   Mahler, Bruno ^b   Carrière, Frédéric ^a  

^a Centre National de la Recherche Scientifique   (France)

^b GATTEFOSSÉ SAS   (France)

Author keywords

Digestive enzyme; Lipase; Lipid excipient; Lipolysis; Oral drug delivery

Indexed keywords

ACYLGLYCEROL; CARBOXYL ESTER HYDROXYLASE; EXCIPIENT; HYDROLASE; LABRASOL; MACROGOL; PANCREATIC LIPASE RELATED PROTEIN 2; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; DIGESTIVE SYSTEM; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; ENZYME ACTIVITY; ENZYME SPECIFICITY; EXPERIMENTAL MODEL; HYDROLYSIS; LIPOLYSIS; NONHUMAN; PANCREAS JUICE; PRIORITY JOURNAL;

ANIMALS; CARBOXYLESTERASE; CATTLE; EMULSIONS; ESTERS; HYDROGEN-ION CONCENTRATION; KINETICS; LIPASE; ORGANIC CHEMICALS; PANCREAS; POLYETHYLENE GLYCOLS; SUBSTRATE SPECIFICITY; SWINE; TRIGLYCERIDES;

SUS;

EID: 34247638077     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.02.009     Document Type: Article

References (50)

1. Gursoy R.N., and Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004) 173-182
2. Vonderscher J., and Meinzer A. Rationale for the development of Sandimmune Neoral. Transplant. Proc. 26 (1994) 2925-2927
3. Palin K.J., Wilson C.G., Davis S.S., and Phillips A.J. The effect of oils on the lymphatic absorption of DDT. J. Pharm. Pharmacol. 34 (1982) 707-710
4. Palin K.J., and Wilson C.G. The effect of different oils on the absorption of probucol in the rat. J. Pharm. Pharmacol. 36 (1984) 641-643
5. Stella V., Haslam J., Yata N., Okada H., Lindenbaum S., and Higuchi T. Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. J. Pharm. Sci. 67 (1978) 1375-1377
6. Kossena G.A., Boyd B.J., Porter C.J., and Charman W.N. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J. Pharm. Sci. 92 (2003) 634-648
7. Lindstrom M., Ljusberg-Wahren H., Larsson K., and Borgstrom B. Aqueous lipid phases of relevance to intestinal fat digestion and absorption. Lipids 16 (1981) 749-754
8. Pouton C.W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. (2006)
9. Chambin O., Jannin V., Champion D., Chevalier C., Rochat-Gonthier M.H., and Pourcelot Y. Influence of cryogenic grinding on properties of a self-emulsifying formulation. Int. J. Pharm. 278 (2004) 79-89
10. Esposito E., Bortolotti F., Menegatti E., and Cortesi R. Amphiphilic association systems for Amphotericin B delivery. Int. J. Pharm. 260 (2003) 249-260
11. Kreilgaard M., Pedersen E.J., and Jaroszewski J.W. NMR characterisation and transdermal drug delivery potential of microemulsion systems. J. Control. Release 69 (2000) 421-433
12. Prasad Y.V., Puthli S.P., Eaimtrakarn S., Ishida M., Yoshikawa Y., Shibata N., and Takada K. Enhanced intestinal absorption of vancomycin with Labrasol and d-alpha-tocopheryl PEG 1000 succinate in rats. Int. J. Pharm. 250 (2003) 181-190
13. Rama Prasad Y.V., Eaimtrakarn S., Ishida M., Kusawake Y., Tawa R., Yoshikawa Y., Shibata N., and Takada K. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs. Int. J. Pharm. 268 (2003) 13-21
14. Rama Prasad Y.V., Minamimoto T., Yoshikawa Y., Shibata N., Mori S., Matsuura A., and Takada K. In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer. Int. J. Pharm. 271 (2004) 225-232
15. Eaimtrakarn S., Rama Prasad Y.V., Ohno T., Konishi T., Yoshikawa Y., Shibata N., and Takada K. Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats. J. Drug Target. 10 (2002) 255-260
16. Hu Z., Tawa R., Konishi T., Shibata N., and Takada K. A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin. Life Sci. 69 (2001) 2899-2910
17. Carriere F., Barrowman J.A., Verger R., and Laugier R. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 105 (1993) 876-888
18. Lengsfeld H., Beaumier-Gallon G., Chahinian H., De Caro A., Verger R., Laugier R., and Carrière F. Physiology of gastrointestinal lipolysis and therapeutical use of lipases and digestive lipase inhibitors. In: Petry S. (Ed). Lipases and Phospholipases in Drug Development (2004), Wiley-VCH, Weinheim 195-229
19. Abrams C.K., Hamosh M., Lee T.C., Ansher A.F., Collen M.J., Lewis J.H., Benjamin S.B., and Hamosh P. Gastric lipase: localization in the human stomach. Gastroenterology 95 (1988) 1460-1464
20. Moreau H., Bernadac A., Gargouri Y., Benkouka F., Laugier R., and Verger R. Immunocytolocalisation of human gastric lipase in chief cells of the fundic mucosa. Histochemistry 91 (1989) 419-423
21. Giller T., Buchwald P., Blum-Kaelin D., and Hunziker W. Two novel human pancreatic lipase related proteins, hPLRP1 and hPLRP2. Differences in colipase dependence and in lipase activity. J. Biol. Chem. 267 (1992) 16509-16516
22. De Caro J., Carrière F., Barboni P., Giller T., Verger R., and De Caro A. Pancreatic lipase-related protein 1 (PLRP1) is present in the pancreatic juice of several species. Biochim. Biophys. Acta 1387 (1998) 331-341
23. De Caro J., Sias B., Grandval P., Ferrato F., Halimi H., Carriere F., and De Caro A. Characterization of pancreatic lipase-related protein 2 isolated from human pancreatic juice. Biochim. Biophys. Acta 1701 (2004) 89-99
24. Lombardo D., Fauvel J., and Guy O. Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice: I. Action on carboxyl esters, glycerides and phospholipids. Biochim. Biophys. Acta 611 (1980) 136-146
25. Verger R., de Haas G.H., and Sarda L. Purification from porcine pancreas of two molecular species with lipase activity. Biochim. Biophys. Acta 188 (1969) 272-282
26. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
27. Erlanson C., and Borgström B. Tributyrin as a substrate for determination of lipase activity of pancreatic juice and small intestinal content. Scand. J. Gastroenterol. 5 (1970) 293-295
28. Carriere F., Moreau H., Raphel V., Laugier R., Benicourt C., Junien J.L., and Verger R. Purification and biochemical characterization of dog gastric lipase. Eur. J. Biochem. 202 (1991) 75-83
29. Christensen J.O., Schultz K., Mollgaard B., Kristensen H.G., and Mullertz A. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur. J. Pharm. Sci. 23 (2004) 287-296
30. Kaukonen A.M., Boyd B.J., Charman W.N., and Porter C.J. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids. Pharm. Res. 21 (2004) 254-260
31. Kaukonen A.M., Boyd B.J., Porter C.J., and Charman W.N. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm. Res. 21 (2004) 245-253
32. Porter C.J., Kaukonen A.M., Boyd B.J., Edwards G.A., and Charman W.N. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm. Res. 21 (2004) 1405-1412
33. Zangenberg N.H., Mullertz A., Kristensen H.G., and Hovgaard L. A dynamic in vitro lipolysis model: I. Controlling the rate of lipolysis by continuous addition of calcium. Eur. J. Pharm. Sci. 14 (2001) 115-122
34. Figarella C. Composition et stabilité de l'équipement enzymatique du pancréas de l'homme et de divers animaux. Bull. Soc. Chim. Biol. 48 (1966) 97-115
35. Guy O., and Figarella C. The proteins of human pancreatic external secretion. Scand. J. Gastroenterol., Suppl. 67 (1981) 59-61
36. Rudd E.A., and Brockman H.L. Pancreatic carboxyl ester lipase (cholesterol esterase). In: Brockman H.L. (Ed). Lipases (1984), Elsevier Science Publishers, Amsterdam 185-204
37. Kyger E.M., Wiegand R.C., and Lange L.G. Cloning of the bovine pancreatic cholesterol esterase/lysophospholipase. Biochem. Biophys. Res. Commun. 164 (1989) 1302-1309
38. Nilsson J., Blaeckberg L., Carlsson P., Enerbaeck S., Hernell O., and Bjursell G. cDNA cloning of human-milk bile-salt-stimulated lipase and evidence for its identity to pancreatic carboxylic ester hydrolase. Eur. J. Biochem. 192 (1990) 543-550
39. Chen J.C., Miercke L.J., Krucinski J., Starr J.R., Saenz G., Wang X., Spilburg C.A., Lange L.G., Ellsworth J.L., and Stroud R.M. Structure of bovine pancreatic cholesterol esterase at 1.6 A: novel structural features involved in lipase activation. Biochemistry 37 (1998) 5107-5117
40. Moore S.A., Kingston R.L., Loomes K.M., Hernell O., Blackberg L., Baker H.M., and Baker E.N. The structure of truncated recombinant human bile salt-stimulated lipase reveals bile salt-independent conformational flexibility at the active-site loop and provides insights into heparin binding. J. Mol. Biol. 312 (2001) 511-523
41. Carrière F., Rogalska E., Cudrey C., Ferrato F., Laugier R., and Verger R. In vivo and in vitro studies on the stereoselective hydrolysis of tri- and diglycerides by gastric and pancreatic lipases. Bioorg. Med. Chem. 5 (1997) 429-435
42. Carrière F., Raphel V., Moreau H., Bernadac A., Devaux M.-A., Grimaud R., Barrowman J.A., Bénicourt C., Junien J.-L., Laugier R., and Verger R. Dog gastric lipase: stimulation of its secretion in vivo and cytolocalization in mucous pit cells. Gastroenterology 102 (1992) 1535-1545
43. Vaganay S., Joliff G., Bertaux O., Toselli E., Devignes M.D., and Benicourt C. The complete cDNA sequence encoding dog gastric lipase. DNA Seq. 8 (1997) 257-262
44. Bodmer M.W., Angal S., Yarranton G.T., Harris T.J.R., Lyons A., King D.J., Piéroni G., Rivière C., Verger R., and Lowe P.A. Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim. Biophys. Acta 909 (1987) 237-244
45. Roussel A., Canaan S., Egloff M.P., Riviere M., Dupuis L., Verger R., and Cambillau C. Crystal structure of human gastric lipase and model of lysosomal acid lipase, two lipolytic enzymes of medical interest. J. Biol. Chem. 274 (1999) 16995-17002
46. Roussel A., Miled N., Berti-Dupuis L., Riviere M., Spinelli S., Berna P., Gruber V., Verger R., and Cambillau C. Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor. J. Biol. Chem. 277 (2002) 2266-2274
47. Thirstrup K., Verger R., and Carrière F. Evidence for a pancreatic lipase subfamily with new kinetic properties. Biochemistry 33 (1994) 2748-2756
48. Piéroni G., and Verger R. Hydrolysis of mixed monomolecular films of triglyceride/lecithin by pancreatic lipase. J. Biol. Chem. 254 (1979) 10090-10094
49. Carriere F., Renou C., Lopez V., De Caro J., Ferrato F., Lengsfeld H., De Caro A., Laugier R., and Verger R. The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals. Gastroenterology 119 (2000) 949-960
50. Sias B., Ferrato F., Grandval P., Lafont D., Boullanger P., De Caro A., Leboeuf B., Verger R., and Carriere F. Human pancreatic lipase-related protein 2 is a galactolipase. Biochemistry 43 (2004) 10138-10148